These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 3494486

  • 1. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
    Horwitz B, Grady CL, Schlageter NL, Duara R, Rapoport SI.
    Brain Res; 1987 Mar 31; 407(2):294-306. PubMed ID: 3494486
    [Abstract] [Full Text] [Related]

  • 2. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
    Horwitz B, Duara R, Rapoport SI.
    Ann Neurol; 1986 Jan 31; 19(1):60-7. PubMed ID: 3484930
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography in Alzheimer's disease.
    Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI.
    Neurology; 1986 Jul 31; 36(7):879-87. PubMed ID: 3487046
    [Abstract] [Full Text] [Related]

  • 4. Cortical abnormalities in Alzheimer's disease.
    Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, Di Chiro G.
    Ann Neurol; 1984 Dec 31; 16(6):649-54. PubMed ID: 6335378
    [Abstract] [Full Text] [Related]

  • 5. Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input.
    Horwitz B, Duara R, Rapoport SI.
    J Cereb Blood Flow Metab; 1984 Dec 31; 4(4):484-99. PubMed ID: 6501442
    [Abstract] [Full Text] [Related]

  • 6. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H, Harada K, Yamauchi H, Miyoshi T, Yamaguchi S, Kimura J, Kameyama M, Senda M, Yonekura Y, Konishi J.
    J Neurol Sci; 1991 Dec 31; 106(2):128-34. PubMed ID: 1802960
    [Abstract] [Full Text] [Related]

  • 7. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.
    Am J Psychiatry; 1997 Aug 31; 154(8):1063-9. PubMed ID: 9247390
    [Abstract] [Full Text] [Related]

  • 8. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP, Budinger TF, Koss E, Ober BA.
    Neurosci Lett; 1985 Feb 04; 53(3):235-40. PubMed ID: 3872424
    [Abstract] [Full Text] [Related]

  • 9. Brain metabolism and blood flow during aging.
    Horwitz B.
    Electroencephalogr Clin Neurophysiol Suppl; 1987 Feb 04; 39():396-402. PubMed ID: 3308421
    [Abstract] [Full Text] [Related]

  • 10. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
    Cutler NR, Haxby JV, Duara R, Grady CL, Moore AM, Parisi JE, White J, Heston L, Margolin RM, Rapoport SI.
    Neurology; 1985 Nov 04; 35(11):1556-61. PubMed ID: 3877253
    [Abstract] [Full Text] [Related]

  • 11. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease.
    Kessler J, Mielke R, Grond M, Herholz K, Heiss WD.
    Int J Neurosci; 2000 Nov 04; 104(1-4):1-15. PubMed ID: 11011970
    [Abstract] [Full Text] [Related]

  • 12. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.
    Am J Psychiatry; 1996 Oct 04; 153(10):1261-8. PubMed ID: 8831432
    [Abstract] [Full Text] [Related]

  • 13. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization.
    Horwitz B, Rumsey JM, Grady CL, Rapoport SI.
    Arch Neurol; 1988 Jul 04; 45(7):749-55. PubMed ID: 3260481
    [Abstract] [Full Text] [Related]

  • 14. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
    Cutler NR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Jul 04; 10(3-5):309-21. PubMed ID: 2948218
    [Abstract] [Full Text] [Related]

  • 15. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF.
    Neurology; 1989 Nov 04; 39(11):1427-34. PubMed ID: 2812318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 04; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease.
    Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B.
    Neurology; 1988 Jun 04; 38(6):909-12. PubMed ID: 3259296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.